Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)
India · Delayed Price · Currency is INR 87.78
+4.18 (5.00%)
Jun 22, 2026, 3:05 PM IST
NSE:AAREYDRUGS Market Cap
NSE:AAREYDRUGS has a market cap or net worth of 2.37 billion as of June 22, 2026. Its market cap has increased by 56.08% in one year.
Market Cap
2.37B
Enterprise Value
2.95B
Revenue
4.72B
Ranking
n/a
PE Ratio
59.83
Stock Price
87.78
Market Cap Chart
Since April 17, 2007, NSE:AAREYDRUGS's market cap has increased from 147.01M to 2.37B, an increase of 1,514.80%. That is a compound annual growth rate of 15.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 2.37B | 25.03% |
| Dec 31, 2025 | 1.90B | 19.77% |
| Dec 31, 2024 | 1.59B | 23.59% |
| Dec 29, 2023 | 1.28B | 30.23% |
| Dec 30, 2022 | 984.93M | -9.47% |
| Dec 31, 2021 | 1.09B | 26.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 14.25B |
| Sigachi Industries | 8.77B |
| Bafna Pharmaceuticals | 3.79B |
| Valiant Laboratories | 3.69B |
| Nectar Lifesciences | 2.22B |
| Brooks Laboratories | 1.96B |
| Alpa Laboratories | 1.43B |
| Balaxi Pharmaceuticals | 1.31B |